Thyroid Cancer Detection by Ultrasound Molecular Imaging with SHP2-Targeted Perfluorocarbon Nanoparticles.

scientific article

Thyroid Cancer Detection by Ultrasound Molecular Imaging with SHP2-Targeted Perfluorocarbon Nanoparticles. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1155/2018/8710862
P932PMC publication ID5863344
P698PubMed publication ID29706844

P50authorZhongQian HuQ88507265
Jia LiQ88507267
P2093author name stringBin Yang
Tiankuan Li
P2860cites workProspective comparative evaluation of quantitative-elastosonography (Q-elastography) and contrast-enhanced ultrasound for the evaluation of thyroid nodules: preliminary experience.Q53098901
Qualitative and quantitative evaluation of solitary thyroid nodules with contrast-enhanced ultrasound: initial resultsQ63719414
Diagnosis of "follicular neoplasm": a gray zone in thyroid fine-needle aspiration cytologyQ77464090
Evaluation of the thyroid noduleQ83878491
Quantitative perfusion analysis of transabdominal contrast-enhanced ultrasonography of pancreatic masses and carcinomasQ84486089
SHP-2 is a novel target of Abl kinases during cell proliferationQ28512136
Imaging tumor angiogenesis with contrast ultrasound and microbubbles targeted to alpha(v)beta3.Q30310994
Biodegradable double-targeted PTX-mPEG-PLGA nanoparticles for ultrasound contrast enhanced imaging and antitumor therapy in vitroQ30360132
Vascular endothelial growth factor receptor type 2-targeted contrast-enhanced US of pancreatic cancer neovasculature in a genetically engineered mouse model: potential for earlier detectionQ30416185
Ultrasound molecular imaging in a human CD276 expression-modulated murine ovarian cancer modelQ30417587
Recent advances in molecular, multimodal and theranostic ultrasound imagingQ30436709
Dual-targeted contrast agent for US assessment of tumor angiogenesis in vivoQ30484195
CD244 maintains the proliferation ability of leukemia initiating cells through SHP-2/p27kip1 signalingQ33574172
Targeted contrast-enhanced ultrasound: an emerging technology in abdominal and pelvic imagingQ34171483
Developments in ultrasound contrast mediaQ34252060
Expression and clinical significance of tyrosine phosphatase SHP2 in thyroid carcinomaQ35943238
Earlier detection of breast cancer with ultrasound molecular imaging in a transgenic mouse model.Q36699083
A tyrosine phosphatase SHP2 gain-of-function mutation enhances malignancy of breast carcinomaQ36905741
Detection of pancreatic ductal adenocarcinoma in mice by ultrasound imaging of thymocyte differentiation antigen 1.Q37198592
Ultrasound microbubbles for molecular diagnosis, therapy, and theranosticsQ37990912
Contrast-Enhanced Ultrasound for the differentiation of benign and malignant focal liver lesions: a meta-analysisQ38083837
Ultrasound contrast agents and ultrasound molecular imagingQ38204404
PTPN11/Shp2 overexpression enhances liver cancer progression and predicts poor prognosis of patientsQ38888315
Overexpression of SHP2 tyrosine phosphatase promotes the tumorigenesis of breast carcinomaQ38991975
Expression and clinical significance of tyrosine phosphatase SHP-2 in colon cancerQ39033280
Role of SHP2 in hematopoiesis and leukemogenesisQ39184182
Inhibition of SHP2 leads to mesenchymal to epithelial transition in breast cancer cellsQ39990859
Molecular profiling of angiogenesis with targeted ultrasound imaging: early assessment of antiangiogenic therapy effectsQ40024036
Monitoring response to anticancer therapy by targeting microbubbles to tumor vasculatureQ40187867
Shp-2 has a positive regulatory role in ES cell differentiation and proliferationQ41018537
Enhanced selective sonosensitizing efficacy of ultrasound-based anticancer treatment by targeted gold nanoparticlesQ46489524
Breast tumor size assessment: comparison of conventional ultrasound and contrast-enhanced ultrasoundQ47275406
Chemical gas-generating nanoparticles for tumor-targeted ultrasound imaging and ultrasound-triggered drug deliveryQ47393461
P275copyright licenseCreative Commons Attribution 4.0 InternationalQ20007257
P6216copyright statuscopyrightedQ50423863
P921main subjectthyroid cancerQ826522
P304page(s)8710862
P577publication date2018-03-08
P1433published inContrast Media & Molecular ImagingQ2995750
P1476titleThyroid Cancer Detection by Ultrasound Molecular Imaging with SHP2-Targeted Perfluorocarbon Nanoparticles
P478volume2018

Reverse relations

cites work (P2860)
Q61803672Current Trends in Cancer Nanotheranostics: Metallic, Polymeric, and Lipid-Based Systems
Q55416268Multimodal Molecular Imaging: Current Status and Future Directions.